Yehoda M Martei, MD, MSCE
Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Attending Physician, Hematology-Oncology, Hospital of the University of Pennsylvania
Adjunct Lecturer, University of Botswana, Gaborone, Botswana
Global Health Scholar, Center for Global Health, Perelman School of Medicine
Vice Chief, Diversity, Inclusion and Health Equity, Hematology - Oncology Division, University of Pennsylvania
Senior Fellow, Leonard Davis Institute (Penn LDI), University of Pennsylvania
Department: Medicine
Contact information
3400 Civic Center Blvd.
Philadelphia, PA 19104
Philadelphia, PA 19104
Publications
Education:
BA (Biology)
Harvard University, 2005.
MD (Medicine)
Yale University School of Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2018.
Permanent linkBA (Biology)
Harvard University, 2005.
MD (Medicine)
Yale University School of Medicine, 2011.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2018.
Selected Publications
Trends in the Use of Hypofractionation in Treatment of Breast Cancer in Botswana: Trends in the Use of Hypofractionation in Treatment of Breast Cancer in Botswana. ASCO Annual Meeting, Chicago, IL June 2025 Notes: "Poster Presentation"Martei YM, Gurram M, Mokokwe LT, Ngwako N, Kebuang K, Setlhako DI, Vuylsteke P, Bontswanetse B, Segadimo T, Mosepele M, Shulman LN, Barg F, Gaolebale BE: Baseline Distress and Effectiveness of Survivor Video Narratives on Cancer-Associated Distress in Botswana: A Pilot Study. JCO Glob Oncol 11: e2400474, June 2025.
Gupta V, Satlin MJ, Yu KC, Martei Y, Sung L, Westblade LF, Howard S, Ai C, Flayhart DC.: Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncology 26(5): 00128-7, May 2025.
Sallah YH, Bratti VF, Rafinejad-Farahani B, Jayasekar Zurn S, Johnson S, Crestani AS, Dacoregio MI, Majeed H, Fazelzad R, Pabani A, Wilson BE, Favorito FM, de Moraes FY, Sung L, Martei YM, Rodin D.: Antimicrobial resistance in patients with haematological malignancies:a scoping review. Lancet Oncol 26(5): e242-e252, May 2025.
Martei,YM: “The Invisible Second Threat to Cancer Patients – Drug-Resistant Infections” One Health Trust Podcast Interview 2025.
Martei YM: “Oncologists need to see antimicrobial resistance as a cancer care delivery crisis.” STAT News 2025.
Gupta V, Satlin MJ, Yu K, Martei YM, Sung L, Westblade LF, Howard SC, Ai C, Flayhart DC: Burden of Antimicrobial Resistance in Adult Hospitalized Patients With Cancer: A Multicancer Analysis. Cancer Med. 13(24): e70495, December 2024.
Diogo de Sousa Neves D, Jayasekar Zürn S, Khuc-Bilon T, Rendler-Garcia M, Martei YM, Krishnamurthy Reddiar S.: The Access to Oncology Medicines Coalition: Enhanced in-Country Coordination for Sustainable Access. Cancer Manag Res 16: 1609-1616, November 2024.
Castillo BS, Boadi T, Han X, Shulman LN, Martei YM.: Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer. JAMA Netw Open 7(10): e2441056, Oct 2024.
Pain D, MacDuffie E, Martei YM, Kassick M, Ikeda DJ, Shulman LN, Salazar LL, Diaz Pardo D, Nag S, Grover S.: Barriers to Implementing a Quality Improvement Program in Low- and Middle-Income Countries: Adequacy of Resources. JCO Glob Oncol 10: e2400114, October 2024.